Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
Total Equity
Creo Medical Group PLC
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Creo Medical Group PLC
LSE:CREO
|
Total Equity
£59.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Total Equity
$5.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Total Equity
$1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
17%
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Total Equity
-$105.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Total Equity
£67.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
Angle PLC
LSE:AGL
|
Total Equity
£32.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Total Equity?
Total Equity
59.8m
GBP
Based on the financial report for Dec 31, 2023, Creo Medical Group PLC's Total Equity amounts to 59.8m GBP.
What is Creo Medical Group PLC's Total Equity growth rate?
Total Equity CAGR 5Y
5%
Over the last year, the Total Equity growth was 21%. The average annual Total Equity growth rates for Creo Medical Group PLC have been -2% over the past three years , 5% over the past five years .